Daniel Allen Gold, Director at Roivant Sciences Ltd. (ROIV), sold 1,438,163 shares at $33.92 ($49.4M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Open-market sale of $49.4M ROIV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.92 | 300,783 | $10.2M | 20.7% |
| 2 | $34.07 | 325,000 | $11.1M | 22.4% |
| 3 | $34.44 | 200,000 | $6.9M | 14.0% |
| 4 | $34.59 | 600,000 | $20.8M | 42.1% |
| 5 | $35.28 | 12,380 | $437K | 0.9% |
| Total | $34.32 avg |
| 1,438,163 |
| $49.4M |
| 100% |
| Filing → |
| ROIV | SELL | 2025-12-18 | $71.8M | — | Filing → |
| ROIV | SELL | 2025-11-21 | $29.8M | — | Filing → |
| ROIV | SELL | 2024-09-26 | $92.7M | — | Filing → |